Journal

The 6AM Journal: peptide research, read slowly

Articles from 6AM Research, grouped into hubs. Every one sourced and dated.

The 6AM mark rendered in glass
Independent lab testingEvery batch, before it ships.
Public COA per batchLook up any batch number.
Invitation-onlyA private, members-only marketplace.
Cold-chain handlingDiscreet packaging, tracked delivery.
Evidence-graded libraryEvery claim sourced and dated.

About this page

The Journal is where 6AM Research explains the research behind the catalogue at reading length: how to interpret a certificate of analysis, what a regulatory vote actually changes, and what a systematic review can and cannot tell you.

Articles are grouped into three hubs so related reading sits together. Each one names its sources, carries a review date and is updated when the science or the rules move. We would rather publish fewer articles that hold up than many that don't.

Regulation

12 entries · Dated, primary-source answers for the US, UK and Australia.

Built around your goals.

Not scientific jargon. Every entry links its sources and its batch.

Request access

One brand. Every goal.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Journal

All articles

Claims vs evidence

Claims vs evidenceBPC-157 claims and the evidence: what studies measuredClaims about BPC-157 rest mostly on rat and cell studies. In people, the only randomised data are conference abstracts (checked 21 Nov 2026).11 min readClaims vs evidenceDo peptides work? Why photos and testimonials are weak evidenceDo peptides work? It depends on the peptide. Approved medicines have reviewed trials; BPC-157 has mostly animal studies. Why photos prove little.12 min readClaims vs evidenceGHK-Cu claims and the evidence: what studies measuredA randomized GHK-Cu skin-care study with 13 completers found no objective difference between groups. See what eyebrow, animal, and cell studies…7 min readClaims vs evidenceMOTS-c Claims vs Evidence: Mouse Data, No Human ResultsClaims about MOTS-c rest on mouse and cell studies: the model, sample and tier behind each. No published study has given it to people; one trial is…10 min readClaims vs evidencePeptides and Energy: What Has Been TestedPeptides and energy: what studies of SS-31, MOTS-c, humanin and the coenzyme NAD+ measured, in which models, and which were given to people.16 min readClaims vs evidencePeptides and Inflammation: What Studies MeasuredPeptides and inflammation: what studies of BPC-157, KPV, thymosin alpha 1, LL-37 and GHK-Cu measured, in which models, and what is unknown.18 min readClaims vs evidencePeptides graded by evidence: where each one’s research stopsTwelve peptides ordered by the strongest study design for each: approved medicines, then controlled human studies, then mostly animal and cell work.16 min readClaims vs evidenceSemax claims and the evidence: what studies measuredSemax’s human studies are few and small: one randomised without a placebo, one imaging study with one. None shows whether or when an effect occurs.8 min read

Comparisons

Comparison5-amino-1MQ vs MOTS-c: identity, evidence and status5-amino-1MQ is a small molecule; MOTS-c is a mitochondrial peptide. Their evidence, human data, regulatory records and anti-doping status differ.10 min readComparisonBPC-157 vs GHK-Cu: Identity, Evidence and StatusBPC-157 and GHK-Cu side by side: what each peptide is, how each has been studied, and its US, UK, Australian and anti-doping status, dated Nov 2026.13 min readComparisonBPC-157 vs KPV: identity, evidence and legal statusBPC-157 has limited human data. FDA staff found none for KPV. Compare their identities, evidence, regulatory status, and sport rules.7 min readComparisonGHK vs GHK-Cu: with and without copperGHK is copper-free; GHK-Cu is its copper complex. Compare their identity, study models and the regulatory and sport findings checked here.8 min readComparisonGHK-Cu vs KPV: identity, evidence and legal statusGHK-Cu is a copper complex; KPV is a three-amino-acid peptide. Their identity, human evidence and regulatory records side by side, dated 21 Nov 2026.8 min readComparisonGHK-Cu vs Matrixyl: Identity, Evidence and StatusGHK-Cu vs Matrixyl: a copper tripeptide and a palmitoyl pentapeptide. How they differ in identity, cosmetic names, evidence and regulatory status.12 min readComparisonGHK-Cu vs NAD+: identity, evidence and statusGHK-Cu is a copper–peptide complex; NAD+ is a coenzyme. Compare their identity, evidence limits and the regulatory records checked here.9 min readComparisonGHK-Cu vs “GLOW”: identity, evidence and legal statusGHK-Cu is a copper–peptide complex. “GLOW” is a blend with no direct study found. Compare human evidence, regulatory records and sport rules.8 min readComparisonGHK-Cu vs “KLOW”: identity, evidence and legal statusGHK-Cu is one peptide; “KLOW” is a seller name for a vial listing GHK-Cu, BPC-157, TB-500 and KPV. We found no study of the mix (21 Nov 2026).11 min readComparisonMOTS-c vs NAD+: identity, evidence and legal statusMOTS-c is a 16-amino-acid peptide; NAD+ is a coenzyme. Compare the evidence and the limits of what US, UK, Australian and sport-status checks show.9 min readComparisonMOTS-c vs SLU-PP-332: identity, evidence and legal statusMOTS-c is a 16-amino-acid peptide; SLU-PP-332 is a small synthetic molecule, not a peptide. Studies that gave either used cells and animals (21 Nov…13 min readComparisonMOTS-c vs SS-31: identity, evidence and legal statusMOTS-c and SS-31 are distinct peptides. Compare their identity, human evidence, U.S. regulatory status, and WADA listings.8 min readComparisonNAD+ vs NMN: identity, evidence and legal statusNAD+ and NMN are different molecules, and neither is a peptide. What each is, what human studies measured, and where FDA and WADA stand.14 min readComparisonPDA peptide vs BPC-157: identity, evidence and statusNo paper, trial record or FDA list we found uses the name PDA. What a 2017 patent on BPC-157 salts, BPC-157’s record and regulators do and do not say.8 min readComparisonRetatrutide vs Cagrilintide: Targets, Trials, StatusRetatrutide vs cagrilintide: investigational peptides from Lilly and Novo Nordisk with different targets and trials, neither approved in the US or EU.11 min readComparison“GLOW” vs “KLOW” Peptide: Composition, Evidence, Status“GLOW” lists GHK-Cu, BPC-157 and TB-500; “KLOW” adds KPV. What each lists, each component’s evidence tier and status, side by side (21 Nov 2026).11 min readComparison“GLOW” vs “Wolverine”: identity, evidence and legal status“GLOW” lists three peptides and “Wolverine” two; the difference is GHK-Cu. We found no study of either mix as sold (21 Nov 2026).11 min read

Legal status by market

Sport · WADAIs BPC-157 Banned in Sport? WADA S0 and Dates (2026)Yes. WADA has named BPC-157 in class S0 since 1 January 2022. The List text, what the Code says, how anti-doping bodies apply it, and what changes in…10 min readLegal status · AustraliaIs BPC-157 Legal in Australia? Poisons Standard (2026)BPC-157 has been Schedule 4, with possession controls, since 1 June 2024. The Poisons Standard text, the TGA’s reasons, the Act and 2026 enforcement.11 min readLegal status · UKIs BPC-157 Legal in the UK? Law, MHRA and Dates (2026)We found no UK law that names BPC-157, and medicines law still applies. The Human Medicines Regulations 2012, MHRA guidance, 2026 enforcement and…11 min readSport · WADAIs GHK-Cu Banned in Sport? WADA Lists 2026 and 2027WADA’s 2026 and 2027 Prohibited Lists do not name GHK-Cu, and WADA says unnamed peptides may still be prohibited. What class S0 says and who decides.9 min readLegal status · AustraliaIs GHK-Cu Legal in Australia? TGA and Cosmetics (2026)The Poisons Standard does not name GHK-Cu, but the TGA lists it among unapproved peptide products. Where the therapeutic-goods and cosmetic rules…10 min readLegal status · UKIs GHK-Cu Legal in the UK? Rules and Status (2026)We found no UK law that names GHK-Cu. How cosmetics law and the Human Medicines Regulations 2012 apply to products containing it, and what the MHRA…10 min readLegal status · USIs GHK-Cu Legal in the US? FDA Status and Dates (2026)We found no US law that names GHK-Cu: intended use decides if a product is a cosmetic or a drug. FDA’s compounding status, three recalls and dates.12 min readSport · WADAIs MOTS-c Banned in Sport? WADA S4.4.1 and Dates (2026)Yes. WADA has named MOTS-c in class S4.4.1, prohibited at all times, since the 2025 List. The List text, what non-Specified means, TUEs and 2027.9 min readLegal status · AustraliaIs MOTS-c Legal in Australia? TGA, Law and Dates (2026)The Poisons Standard does not name MOTS-c, but the TGA says supplying unapproved peptide products is unlawful. The Act, the 2026 record and sport.10 min readLegal status · UKIs MOTS-c Legal in the UK? MHRA, Law and Dates (2026)We found no UK law that names MOTS-c, and medicines law still applies. The Human Medicines Regulations 2012, MHRA guidance, the 2026 record and sport.11 min readLegal status · USIs MOTS-c Legal in the US? FDA Status and Dates (2026)MOTS-c is not FDA-approved or on the 503A bulks list, and a draft HHS compounding policy of October 2026 names it. FDA’s category history and dates.11 min readSport · WADAIs Retatrutide Banned in Sport? WADA S0 and DatesWADA’s 2026 and 2027 Lists do not name retatrutide, and WADA says an unnamed peptide may still be prohibited. Class S0 and who decides, dated.10 min readLegal status · AustraliaIs Retatrutide Legal in Australia? TGA Status (2026)Retatrutide is not approved in Australia. What the TGA says, how the Therapeutic Goods Act and Poisons Standard apply, 2026 enforcement and sport.11 min readLegal status · UKIs Retatrutide Legal in the UK? MHRA and Dates (2026)Retatrutide is not authorised in the UK, and the MHRA says selling it is illegal. Its statements, the medicines law it enforces, raids and dates.11 min readLegal status · USIs Retatrutide Legal in the US? FDA Status (2026)Retatrutide is not FDA-approved, and FDA says it cannot be used in compounding under federal law. Its statements, warning letters since 2024, dated.10 min read

Safety records

Safety recordMOTS-c side effects: what has been reported, and by whomMOTS-c has no established human safety profile. See what a registered trial plans to measure, what FDA found, and whom the trial excludes.7 min readSafety recordPT-141 side effects: what has been reported, and by whomA human safety profile exists for regulated bremelanotide, not online products labelled PT-141. See trial and FDA label reports, and their limits.8 min readSafety recordRetatrutide Side Effects: What the Trials RecordedRetatrutide side effects by trial: most often gastrointestinal, with discontinuation rates, deaths and FDA reports. Investigational, approved nowhere.14 min readSafety recordSemax side effects: what has been reported, and by whomFDA found too little human safety information to characterize Semax. Its review records one consumer report and sparse study reporting, not an event…7 min readSafety recordTB-500 side effects: what has been reported, and by whomWe found no published controlled study of TB-500 in people; FDA staff call its potential risks unknown. What regulators, a report and a trial record…14 min readSafety record“GLOW” Side Effects: What Is Recorded and What Isn’t“GLOW” side effects are unknown: we found no study of the three-peptide mix. What FDA, the TGA and HHS have recorded on its ingredients and blends.11 min readSafety record“KLOW” side effects: what has been reported, and by whom“KLOW” has no established human safety profile. What FDA reviews, component studies, and published cases can and cannot tell us about the blend.8 min readSafety record“Wolverine” side effects: what has been reportedA human safety profile for the BPC-157 and TB-500 mix is not established. This page separates case reports, studies, and FDA findings.9 min read